C
CervoMed Inc. (CRVO)
NCM – Real Time Price. Currency in USD
2.25
-0.64 (-22.15%)
At close: Jun 10, 2026, 4:00 PM EDT
2.40
+0.15 (6.67%)
After-hours: Jun 10, 2026, 7:39 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
2.25
-0.64 (-22.15%)
At close: Jun 10, 2026, 4:00 PM EDT
2.40
+0.15 (6.67%)
After-hours: Jun 10, 2026, 7:39 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.25 | 6.05 | 10 | |
| Quick ratio | 3.25 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | 7M | 10M | 4M | 2M |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Operating Income | -3M | -8M | -18M | -28M | -31M |
| Net Income | -6M | -2M | -16M | -27M | -30M |
| EBITDA | -3M | -8M | -18M | -28M | -31M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -97.56 | -14.08 | 1.0 |
| Next quarter | -77.86 | 31.46 | 5.5 |
| Current year | -94.3 | 9.49 | 3.5 |
| Next year | 264.58 | 8.92 | 8.0 |
| Weighted average score | 4.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -99.99 | 1.52 | 2.27 | -21.93 | 2.0 |
| Y/Y | -99.99 | -62.72 | -53.56 | -105.89 | 1.0 |
| 3y average | 325.48 | -217.66 | -96.91 | -117.75 | 3.3 |
| 5y average | 594.89 | -129.38 | -59.05 | -55.59 | 3.3 |
| Weighted average score | 2.4 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Cash reserves $7.9M barely cover the upcoming debt maturities $0.0
Total current assets $14.6M exceed Total current liabilities $4.5M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$8.0M limits the company's ability to reinvest or pay down debt